These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 5612464)

  • 1. [The status of the blood coagulation system in patients with congenital and acquired heart defects before and after surgery].
    Khrushcheva EA; Titova MI
    Eksp Khir Anesteziol; 1967; 12(1):71-6. PubMed ID: 5612464
    [No Abstract]   [Full Text] [Related]  

  • 2. [Changes in the blood fibrinase activity in patients with congenital and acquired heart defects].
    Krushcheva EA; Titova MI
    Lab Delo; 1971; 6():348-51. PubMed ID: 4108749
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of surgical intervention on leukocyte osmotic resistance in heart defects].
    Miansatian IT; Chilingarova MV
    Zh Eksp Klin Med; 1978; 18(4):82-7. PubMed ID: 706896
    [No Abstract]   [Full Text] [Related]  

  • 4. [Study of hemostasis in open-heart surgery with extracorporeal circulation].
    Cutcudache C; Voronca G; Marinesco A; Gorun V; Brailesco G; Filipesco S
    Ann Chir Thorac Cardiovasc; 1967 Jul; 6(3):341-7. PubMed ID: 5618388
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of blood lactic acid in congenital and acquired heart diseases in the childhood].
    Barbero S
    Minerva Pediatr; 1969 Dec; 21(48):2266-74. PubMed ID: 5363368
    [No Abstract]   [Full Text] [Related]  

  • 6. [Preoperative and postoperative fluorescence-serologic studies in patients with congenital and acquired heart diseases].
    Raue I; Raue W; Emmrich K
    Dtsch Gesundheitsw; 1966 Sep; 21(38):1781-5. PubMed ID: 5341929
    [No Abstract]   [Full Text] [Related]  

  • 7. [Blood coagulation during extracorporeal circulation--with special reference to blood coagulation in congenital heart defects].
    Yoshida K
    Igaku Kenkyu; 1971 Sep; 41(6):453-70. PubMed ID: 5168959
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the coagulation and anticoagulation system of the blood in patients with congenital defects of the heart of the cyanotic type].
    Iufit SE; Zargarli FI; Tolpekin VE
    Kardiologiia; 1967 Mar; 7(3):136-7. PubMed ID: 5604602
    [No Abstract]   [Full Text] [Related]  

  • 9. [PECULIARITIES OF CHANGED INDICES OF BLOOD COAGULATION AND FIBRINOLYTIC ACTIVITY IN PATIENTS WITH CONGENITAL HEART DEFECTS OPERATED UPON UNDER MODERATE HYPOTHERMIA].
    TERENTEVA LM
    Grudn Khir; 1963; 5():25-30. PubMed ID: 14070968
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experiences with open heart surgery for congenital and acquired heart defects].
    Spath F; Kraft-Kinz J; Finsterbusch W
    Klin Med Osterr Z Wiss Prakt Med; 1967; 22(8):381-4. PubMed ID: 5632411
    [No Abstract]   [Full Text] [Related]  

  • 11. [Metabolic criteria of pathogenetic differentiated transfusion therapy in heart surgery].
    Danilenko MV; Glants RM; Krivoruchko RA; Kaniuk II; Skovronskaia EV
    Klin Khir (1962); 1979 Mar; (3):21-5. PubMed ID: 439650
    [No Abstract]   [Full Text] [Related]  

  • 12. [Characteristics of the alteration in the oxygen transport function of the blood in the early postoperative period in open-heart surgery patients].
    Khodas MIa; Mosolova LA; Abbakumov VV; Grishchenko MN; Grushetskaia GA
    Anesteziol Reanimatol; 1978; (3):29-33. PubMed ID: 686461
    [No Abstract]   [Full Text] [Related]  

  • 13. [The reaction of the organism to extracorporeal circulation in the correction of congenital and acquired heart defects].
    Finsterbusch W; Friehs G
    Klin Med Osterr Z Wiss Prakt Med; 1966 Mar; 21(3):114-9. PubMed ID: 6013377
    [No Abstract]   [Full Text] [Related]  

  • 14. [The changes in coagulation factor XIII after open heart surgery].
    Yaku H; Yamamoto F; Kawazoe K; Nakajima N; Uchida K; Fujita T
    Nihon Kyobu Geka Gakkai Zasshi; 1988 Sep; 36(9):2036-43. PubMed ID: 3204292
    [No Abstract]   [Full Text] [Related]  

  • 15. Thrombin regulation in neonates undergoing cardiopulmonary bypass.
    Långström S; Rautiainen P; Mildh L; Peltola K; Wartiovaara-Kautto U; Heikinheimo M; Petäjä J
    Thromb Haemost; 2008 Apr; 99(4):791-2. PubMed ID: 18392343
    [No Abstract]   [Full Text] [Related]  

  • 16. Coagulation and fibrinolytic profile of paediatric patients undergoing cardiopulmonary bypass.
    Chan AK; Leaker M; Burrows FA; Williams WG; Gruenwald CE; Whyte L; Adams M; Brooker LA; Adams H; Mitchell L; Andrew M
    Thromb Haemost; 1997 Feb; 77(2):270-7. PubMed ID: 9157580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Indications for surgical treatment of acquired and congenital heart defects. (I)].
    Hager W
    Med Welt; 1965 Oct; 44():2463-9 contd. PubMed ID: 5326134
    [No Abstract]   [Full Text] [Related]  

  • 18. [The relation of postoperative pneumonia with changes in the blood coagulation and anticoagulation systems in patients with congenital diseases of the heart of the blue type].
    Galankin NK; Khrushcheva EA; Kaĭdash AN
    Grudn Khir; 1965; 7(5):38-41. PubMed ID: 5888725
    [No Abstract]   [Full Text] [Related]  

  • 19. [Indications for surgical treatment of acquired and congenital heart defects (II)].
    Hager W
    Med Welt; 1965 Nov; 45():2551-5. PubMed ID: 5886323
    [No Abstract]   [Full Text] [Related]  

  • 20. [Artificial blood circulation in the surgery of heart defects (experience with 1136 operations)].
    Amosov NM; Sidarenko LN; Chepkiĭ LP; Bendet IaA
    Khirurgiia (Mosk); 1968 May; 44(5):17-24. PubMed ID: 5682987
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.